Alec Stranahan is a financial analyst currently working in Biotechnology Equity Research at Bank of America. In this role, he covers US SMid-cap Biotech companies, leveraging his extensive background in both finance and scientific research.

Stranahan completed his graduate training at Cornell University, where he earned both a Ph.D. in Molecular Biology and an MBA in Finance.